Circulation: Cardiovascular Interventions

MAY 24, 2024

Circulation: Cardiovascular Interventions, Ahead of Print.

Cardiovascular Interventions 40

Cardiovascular Interventions Aortic Outcomes Circulation 40

DAIC

APRIL 5, 2024

The acquisition of Shockwave further extends Johnson & Johnson MedTech’s position in cardiovascular intervention and accelerates its shift into higher-growth markets. Cardiovascular intervention is one of the fastest-growing global medtech markets, with significant unmet patient need.

Cardiovascular Interventions 105

Cardiovascular Interventions Technology Innovation Angina 105

Circulation: Cardiovascular Interventions

MARCH 17, 2025

Circulation: Cardiovascular Interventions, Volume 18, Issue 3 , Page e014899, March 1, 2025. BACKGROUND:Ineligibility for surgical revascularization is increasingly prevalent and associated with increased mortality after percutaneous coronary intervention (PCI).

Coronary Artery Disease 40

Coronary Artery Disease Outcomes Myocardial Infarction Cardiovascular Interventions 40

Circulation: Cardiovascular Interventions

JANUARY 24, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. Principal safety outcomes were independently adjudicated International Society on Thrombosis and Haemostasis major bleeding at 72 hours post-treatment and mortality within 12 months of treatment.

Embolism 75

Embolism Thrombolysis Ultrasound Pulmonary 75

Circulation: Cardiovascular Interventions

JUNE 10, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. We reported the feasibility and short-term outcomes of percutaneous transcatheter therapy with cerebral embolic protection. BACKGROUND:Surgery or fibrinolysis is the currently available evidence-based treatment for obstructive mechanical valve thrombus.

Embolism 40

Embolism Bicuspid/Mitral Outcomes Cardiovascular Interventions 40

Circulation: Cardiovascular Interventions

JANUARY 20, 2025

Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014681, January 1, 2025.

Cardiovascular Interventions 40

Cardiovascular Interventions Outcomes Circulation 40

Open Heart

JULY 17, 2023

Objective Deferral of non-emergency cardiac procedures is associated with increased early emergency cardiovascular hospitalisation. This study aimed to identify predictors of worse clinical outcome after deferral of non-emergency cardiovascular interventions. Arterial hypertension (HR 2.27; 95% CI 1.00

COVID-19 52

COVID-19 Outcomes Cardiovascular Interventions Risk Factors 52

Circulation: Cardiovascular Interventions

JANUARY 20, 2025

Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014499, January 1, 2025. BACKGROUND:The aim of this study was to examine the impact of early versus delayed catheter-based therapies (CBTs) on clinical outcomes in patients with acute intermediate-risk pulmonary embolism (PE).METHODS:This days;P=0.046).

Embolism 40

Embolism Pulmonary Outcomes Cardiac Arrest 40

Circulation: Cardiovascular Interventions

MARCH 17, 2025

Circulation: Cardiovascular Interventions, Volume 18, Issue 3 , Page e014819, March 1, 2025. However, the risk of 1-year mortality was not higher in nondegenerative etiologies compared with DMR.

Bicuspid/Mitral 40

Bicuspid/Mitral Outcomes Heart Failure Cardiovascular Interventions 40

Circulation: Cardiovascular Interventions

JANUARY 20, 2025

Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014991, January 1, 2025.

Tricuspid 40

Tricuspid Cardiovascular Interventions Circulation Outcomes 40

Circulation: Cardiovascular Interventions

JULY 29, 2024

Circulation: Cardiovascular Interventions, Ahead of Print.

Article 40

Article Cardiovascular Interventions Embolism Bicuspid/Mitral 40

American College of Cardiology

JUNE 24, 2024

Greater adverse events were associated with both low and high postprocedural aortic valve mean gradient extremes following transcatheter aortic valve implantation (TAVI) for degenerated surgical aortic valve replacement (SAVR) bioprostheses, indicating a complex and nonlinear relationship between gradients and clinical outcomes, according to a recent (..)

Aortic valve 53

Aortic valve Aortic Cardiovascular Interventions Circulation 53

Circulation: Cardiovascular Interventions

DECEMBER 27, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. Inverse probability weighting was used to assess the impact of IVUS on a composite outcome of repeat aortic intervention or death.

Ultrasound 40

Ultrasound Aortic Medicaid Medicare 40

Circulation: Cardiovascular Interventions

NOVEMBER 28, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:There are limited data regarding the safety of deferral of percutaneous coronary intervention based on intravascular ultrasound (IVUS) findings. versus 4.1%; hazard ratio, 0.91 [95% CI, 0.47–1.75];P=0.77). 1.75];P=0.77). 2.19];P=0.81) and FFR (4.1%

Outcomes 40

Outcomes Myocardial Infarction Ultrasound Stenosis 40

Circulation: Cardiovascular Interventions

OCTOBER 22, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. Background:Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Primary outcome was all-cause mortality. Primary outcome was all-cause mortality.

Aortic valve 40

Aortic valve Aortic TAVR Outcomes 40

Circulation: Cardiovascular Interventions

FEBRUARY 27, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. Propensity score matching was utilized to compare adjusted outcomes between patients receiving advanced therapies versus anticoagulation alone.Results:A total of 345 patients were included in the study. The primary end point was 90-day all-cause mortality.

Outcomes 40

Outcomes Thrombolysis Embolism Pulmonary 40

Circulation: Cardiovascular Interventions

JANUARY 20, 2025

Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014592, January 1, 2025. We additionally compared end points across treatment arms using trial-adjudicated outcomes versus claims-based outcomes.RESULTS:Trial-adjudicated deaths were perfectly identified by claims.

Aortic valve 40

Aortic valve Outcomes Pacemaker Aortic 40

Circulation: Cardiovascular Interventions

DECEMBER 28, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. We compared outcomes between the conventional implantation method using the 3-cusps view (3 cusps without ICE group), the recent method using cusp-overlap view (cusp overlap without ICE group), and our novel method using ICE (cusp overlap with ICE group).RESULTS:Of

Aortic valve 76

Aortic valve Aortic Pacemaker Cardiovascular Interventions 76

Circulation: Cardiovascular Interventions

JANUARY 18, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Limited data exist regarding the impact of mitral annular calcification (MAC) on outcomes of transcatheter edge-to-edge repair for mitral regurgitation (MR).METHODS:We with functional MR) who underwent an isolated, first-time intervention. versus 29.9%,P=0.060;

Bicuspid/Mitral 40

Bicuspid/Mitral Outcomes Heart Failure Echocardiogram 40

Circulation: Cardiovascular Interventions

OCTOBER 17, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce.

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic Tricuspid 40

Circulation: Cardiovascular Interventions

MARCH 30, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. Background:Optical coherence tomography (OCT) provides high-resolution intracoronary imaging. Updated guidelines should strengthen recommendations supporting the use of OCT guidance for complex PCI.

Thrombosis 40

Thrombosis Myocardial Infarction Stent Stents 40

Circulation: Cardiovascular Interventions

DECEMBER 28, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Lower-limb amputation rates in patients with chronic limb-threatening ischemia vary across the United States, with marked disparities in amputation rates by gender, race, and income status.

Vascular Care 61

Vascular Care Ischemia Medicare Hospital 61

Circulation: Cardiovascular Interventions

NOVEMBER 6, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. Data on transcatheter palliation are limited.Methods:We present our experience with pulmonary flow restrictors (PFRs) for palliation of neonates with congenital heart disease, including procedural feasibility, technical details, and outcomes. kilograms [IQR, 2.1–3.3])

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pulmonary 40

Circulation: Cardiovascular Interventions

MARCH 26, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. The primary outcome was a composite of death from any cause, stroke/transient ischemic attack, and procedure-related or valve-related hospitalization at 30 days and at 1 year. versus 4.3%; hazard ratio, 2.93 [95% CI, 1.455.94]). andP=0.001, respectively).

Aortic valve 40

Aortic valve Aortic Stenosis TAVR 40

Circulation: Cardiovascular Interventions

JANUARY 24, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Intravascular imaging (IVI) is widely recognized to improve outcomes after percutaneous coronary intervention (PCI). in 2010 to 43.1% in 2022 in 136 071 PCIs included in the study.

Hospital 45

Hospital Ultrasound Cardiovascular Interventions Outcomes 45

Circulation: Cardiovascular Interventions

MARCH 20, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. Procedural outcomes, 30-day survival, and echo findings are reported.RESULTS:Fourteen patients (71% women, mean age 77.9 BACKGROUND:Many patients with atrial functional mitral regurgitation are not suitable candidates for surgery or transcatheter repair.

Bicuspid/Mitral 40

Bicuspid/Mitral Atrial Fibrillation Anatomy Echocardiogram 40

Circulation: Cardiovascular Interventions

FEBRUARY 27, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:The American College of Cardiology Reduce the Risk: PCI Bleed Campaign was a hospital-based quality improvement campaign designed to reduce post-percutaneous coronary intervention (PCI) bleeding events.

Myocardial Infarction 45

Myocardial Infarction Hospital Cardiovascular Interventions Outcomes 45

Cardiology Update

JULY 28, 2024

A recent study published in JACC: Cardiovascular Interventions has provided new insights into the long-term management of patients suffering from recurrent in-stent restenosis (ISR), a condition presenting notable challenges in cardiovascular treatment. Original article: Koch T et al. J Am Coll Cardiol Intv.

Stents 52

Stents Stent Cardiovascular Interventions Research 52

Circulation: Cardiovascular Interventions

NOVEMBER 20, 2023

Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e012966, November 1, 2023. Conversely, TAVR-explant can be offered to most patients who are surgical candidates, but the reported outcomes have shown high mortality and morbidity.

Aortic valve 40

Aortic valve Aortic TAVR Heart Valves 40

ADN Center of Excellence

SEPTEMBER 12, 2024

Through these live demonstrations, participants were able to witness how advanced imaging techniques assist in decision-making and optimize patient outcomes in coronary interventions. We remain committed to offering continued opportunities for advanced education in coronary and cardiovascular interventions.

Hospital 59

Hospital Education Technology Cardiovascular Interventions 59

Circulation: Cardiovascular Interventions

JANUARY 23, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. kg at all Congenital Cardiac Catheterization Project on Outcomes participating centers. kg at all Congenital Cardiac Catheterization Project on Outcomes participating centers.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pediatrics 40

Circulation: Cardiovascular Interventions

APRIL 7, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. Cost and utilization outcomes by stage of cardiac damage were estimated using covariate-adjusted generalized linear models.RESULTS:A total of 24 644 patients with AVR were included in our analysis. in stage 0, 17.1% in stage 1, 37.3% in stage 2, 36.2% in stage 4.

Aortic valve 40

Aortic valve Aortic Heart Failure Quality of Life 40

Circulation: Cardiovascular Interventions

MARCH 24, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. The primary outcome was RA graft failure (modified Fitzgibbon grade B, S, or O) at 1 and 24 weeks, assessed by coronary computed tomography angiography.RESULTS:Among 150 randomized participants, 149 (mean age, 56.8

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Cardiovascular Interventions Circulation Outcomes 40

Open Heart

SEPTEMBER 4, 2023

However, this has been associated with delays to treatment, in breach of British Cardiovascular Intervention Society targets. The main outcome of time to TAVI was calculated as the time from Heart Valve Centre referral to TAVI, or alternative intervention, expressed in days.

Heart Valves 52

Heart Valves Aortic valve Aortic Outpatient 52

Circulation: Cardiovascular Interventions

DECEMBER 4, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. Whereas the field of transradial arterial access for peripheral vascular interventions is in development, it is clear that this approach, at least with available equipment, will not be suitable for all patients, and careful case selection is paramount.

Cardiovascular Interventions 40

Cardiovascular Interventions Technology Circulation Hospital 40

Circulation: Cardiovascular Interventions

JANUARY 24, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Transcatheter heart valve (THV) underexpansion after transcatheter aortic valve replacement may be associated with worse outcomes.

Heart Valves 40

Heart Valves Aortic valve TAVR Aortic 40

Circulation: Cardiovascular Interventions

DECEMBER 27, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Varying rates of nonsustained ventricular tachycardia (NSVT) have been reported early after transcatheter pulmonary valve replacement (TPVR) with the Harmony valve, but data regarding rhythm outcomes beyond hospital discharge are limited.

Pulmonary 40

Pulmonary Arrhythmia Cardiovascular Interventions Tachycardia 40